Thiago Andrade Patente

Thiago Andrade Patente

Auto-generated profile, based on publicly available information

Thiago Andrade Patente

Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
TPThiago A. Patente
Thiago A. Patente
MPMariana P. Pinho
Mariana P. Pinho
AOAline A. Oliveira
Aline A. Oliveira
GEGabriela Coeli Menezes Evangelista
Gabriela Coeli Menezes Evangelista
PBPatrícia C. Bergami-Santos
Patrícia C. Bergami-Santos
JBJosé Alexandre Marzagao Barbuto
José Alexandre Marzagao Barbuto
Dendritic cells (DC) are professional antigen presenting cells, uniquely able to induce naïve T cell activation and effector differentiation. They are, likewise, involved in the induction and maintenance of immune tolerance in homeostatic conditions. Their phenotypic and functional heterogeneity points to their great plasticity and ability to modulate, according to their microenvironment, the acquired immune response and, at the same time, makes their precise classification complex and frequently subject to reviews and improvement. This review will present general aspects of the DC physiology and classification and will address their potential and actual uses in the management of human disease, more specifically cancer, as therapeutic and monitoring tools. New combination treatments with the participation of DC will be also discussed.

1 June 2019 in Current Opinion in Immunology
Verified
Journal Article
Open access
TPThiago A Patente
Thiago A Patente
LPLeonard R Pelgrom
Leonard R Pelgrom
BEBart Everts
Bart Everts
Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in the priming and differentiation of CD4+ T cells into several distinct subsets including effector T helper (Th) 1, Th17 and Th2 cells, as well as regulatory T cells (Tregs). It is becoming increasingly clear that cellular metabolism shapes the functional properties of DCs. Specifically, the ability of DCs to drive polarization of different Th cell subsets may be orchestrated by the engagement of distinct metabolic pathways. In this review, we will discuss the recent advances in the DC metabolism field, by focusing on how cellular metabolism of DCs shapes their priming and polarization of distinct Th cell responses.

15 January 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
KMKamel Mohammedi
Kamel Mohammedi
NBNaïma Bellili-Muñoz
Naïma Bellili-Muñoz
SMStefan L Marklund
Stefan L Marklund
FDFathi Driss
Fathi Driss
HNHervé Le Nagard
Hervé Le Nagard
GVGilberto Velho
Gilberto Velho
Oxidative stress is involved in development of diabetes complications. Extracellular superoxide dismutase (EC-SOD, SOD3) is a major extracellular antioxidant enzyme and is highly expressed in arterial walls. Advanced oxidation protein products (AOPP) and 8-iso-prostaglandin (isoprostane) are markers of oxidative stress. We investigated association of SOD3 gene variants, plasma concentrations of EC-SOD, AOPP and isoprostane with myocardial infarction and mortality in diabetic patients. We studied three cohorts designed to evaluate the vascular complications of diabetes: the GENEDIAB study (469 participants with type 1 diabetes at baseline; follow-up data for 259 participants), the GENESIS study (603 participants with type 1 diabetes at baseline; follow-up data for 525 participants) and the DIABHYCAR study (3137 participants with type 2 diabetes at baseline and follow-up). Duration of follow-up was 9, 5, and 5 years, respectively. Main outcome measures were incidence of myocardial infarction, and cardiovascular and total mortality during follow-up. Six single nucleotide polymorphisms in the SOD3 locus were genotyped in the three cohorts. Plasma concentrations of EC-SOD, AOPP, and isoprostane were measured in baseline samples of GENEDIAB participants. In GENEDIAB/GENESIS pooled cohorts, the minor T-allele of rs2284659 variant was inversely associated with the prevalence at baseline (Odds Ratio 0.48, 95% CI 0.29–0.78, p = 0.004) and the incidence during follow-up of myocardial infarction (Hazard Ratio 0.58, 95% CI 0.40–0.83, p = 0.003) and with cardiovascular (HR 0.33, 95% CI 0.08–0.74, p = 0.004) and all-cause mortality (HR 0.44, 95% CI 0.21–0.73, p = 0.0006). The protective allele was associated with higher plasma EC-SOD and lower plasma AOPP concentrations in GENEDIAB. It was also inversely associated with incidence of myocardial infarction (HR 0.75, 95% CI 0.59–0.94, p = 0.01) and all-cause mortality (HR 0.87, 95% CI 0.79–0.97, p = 0.008) in DIABHYCAR. The T-allele of rs2284659 in the promoter of SOD3 was associated with a more favorable plasma redox status and with better cardiovascular outcomes in diabetic patients. Our results suggest that EC-SOD plays an important role in the mechanisms of vascular protection against diabetes-related oxidative stress.

1 February 2016 in Metabolism
Verified
Journal Article
Closed access
KMKamel Mohammedi
Kamel Mohammedi
TPThiago A. Patente
Thiago A. Patente
NBNaima Bellili-Muñoz
Naima Bellili-Muñoz
FDFathi Driss
Fathi Driss
HNHervé Le Nagard
Hervé Le Nagard
GVGilberto Velho
Gilberto Velho

2 April 2019 in Cell Research
Verified
Journal Article
Closed access
PDF file
LPLeonard R. Pelgrom
Leonard R. Pelgrom
TPThiago A. Patente
Thiago A. Patente
ASAlexey Sergushichev
Alexey Sergushichev
EEEkaterina Esaulova
Ekaterina Esaulova
FOFrank Otto
Frank Otto
BEBart Everts
Bart Everts

1 February 2018 in Clinical Immunology
Verified
Journal Article
Closed access
JSJaine L.S. Soares
Jaine L.S. Soares
FFFernanda Pereira Fernandes
Fernanda Pereira Fernandes
TPThiago Andrade Patente
Thiago Andrade Patente
MMMaria B. Monteiro
Maria B. Monteiro
MPMaria C. Parisi
Maria C. Parisi
APAlessandra Pontillo
Alessandra Pontillo